retatrutide blindness the wonder drug: What's Established, What's Plausible, What's Still a Hypothesis — WellFounded - Founders Health & Concierge Performance Medicine diabetes #retatrutide #cardiometabolic #clinicalpractice #glp1

Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study

Either you must have a body mass index (BMI) of 30 or over or have a BMI measuring 27 or above with a weight-related health condition, such as: High blood pressure High cholesterol Type 2 diabetes Sleep apnea Heart disease We calculate your BMI based on your height and weight

Repurposing antidiabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience

The core difference is receptor targeting

2 The relationship between obesity and MASLD is tightly intertwined

As relatively new drugs, though, Ozempic and Wegovy may have more side effects waiting in the wings